Candel Therapeutics (CADL) Change in Account Payables: 2020-2023
Historic Change in Account Payables for Candel Therapeutics (CADL) over the last 3 years, with Dec 2023 value amounting to $172,000.
- Candel Therapeutics' Change in Account Payables rose 131.62% to $172,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $45,000, marking a year-over-year increase of 103.71%. This contributed to the annual value of -$185,000 for FY2024, which is 511.11% down from last year.
- Per Candel Therapeutics' latest filing, its Change in Account Payables stood at $172,000 for Q4 2023, which was up 180.37% from -$214,000 recorded in Q3 2023.
- In the past 5 years, Candel Therapeutics' Change in Account Payables ranged from a high of $818,000 in Q3 2020 and a low of -$579,000 during Q1 2022.
- In the last 3 years, Candel Therapeutics' Change in Account Payables had a median value of $43,500 in 2023 and averaged -$41,583.
- In the last 5 years, Candel Therapeutics' Change in Account Payables skyrocketed by 223.61% in 2021 and then slumped by 434.68% in 2022.
- Candel Therapeutics' Change in Account Payables (Quarterly) stood at -$538,000 in 2020, then spiked by 223.61% to $665,000 in 2021, then tumbled by 181.80% to -$544,000 in 2022, then spiked by 131.62% to $172,000 in 2023.
- Its Change in Account Payables stands at $172,000 for Q4 2023, versus -$214,000 for Q3 2023 and -$62,000 for Q2 2023.